researcher/consumer - needs patient/caregiver assistance - please respond per message below - colonic stents/ovarian cancer

Can anyone - survivour and/or caregiver help here, with great thanks. A friend/researcher is looking  for specific information relating to colon stents and ovarian cancer, As I do not have any personal experience with stents,  it would be very unwise for me to comment. Your input, positive and or negative would be very helpful. If you wish, I will include your name and address when I forward on the information (permission). Please post either to the blog or  to me at: sandipn@sympatico.ca
Thanks as always.
Sandi  Pniauskas

http://ovariancancerandus.blogspot.com

request as below:

"I wonder if you can help me with some 'consumer input' into the use of stents ch stoma and no intervention eg relief with stents, for how long, eating and energy, and harmful effects

 

I am trying to do a response to a health technology assessment - for introduction of the stents.

 

I can talk about the trauma of partial and complete blockages in the late stages of cancer, but not specifically stents

 

If you have the time to jot down a few points that would be really appreciated."

abstract: Radiation-Induced Micro-RNA Expression Changes in Peripheral Blood Cells of Radiotherapy Patients

Conclusions

Exposure to ionizing radiation leads to the upregulation of the expression of a considerable proportion of the human miRNAome of peripheral blood cells. These miRNA expression signatures can be used as biomarkers of radiation exposure.

abstract: (breast cancer) Timing of Radiotherapy and Outcome in Patients Receiving Adjuvant Endocrine Therapy

2011 ovarian cancer annual conference registration | Ovarian Cancer National Alliance early bird discounts expire May 31st

OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment - press release - 2nd study

Second study in Obstetrics & Gynecology showcases OVA1's role in evaluating women with an ovarian mass

 "In the manuscript "Effectiveness of a Multivariate Index Assay in the Preoperative Assessment of Ovarian Tumors," physician assessment and the use of OVA1 correctly identified 70% of malignancies missed by physician assessment among gynecologists and other non-gynecologic oncologists, and 95% of malignancies missed by physician assessment among gynecologic oncologists. OVA1 also detected 76% of malignancies that would have been missed by CA 125 using ACOG-recommended guidelines......"

Comment from affiliated blog: Survivors' Debate - CANO presentation

posted comment:

arizona cancer treatment said...

Well explained. I am a researcher and these details were lot helpful for my research. Thanks for sharing. Stay in touch and keep posting.

22 May, 2011 

WELCOME - Genetic Alliance - tell your story and/or survey - DNA information

Have you ever needed or wanted to use your DNA information in making healthcare decisions? If so, I am interested in your story!

This website provides an opportunity for those of you who want to share your story including:

1. •those already using DNA information in your healthcare decisions
   

2. •those who have decided not to use DNA information
   

"Changes are underway in the way healthcare will occur - based on our own DNA, more interactive, predictive, and *personalized."